Biomolecules & Therapeutics

  • 제17권4호
  • /
  • Pages.403-411
  • /
  • 2009
  • /
  • 1976-9148(pISSN)
  • /
  • 2005-4483(eISSN)
한국응용약물학회 (The Korean Society of Applied Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Anti-Cancer Effect of the Combination of Thiacremonone and Docetaxel by Inactivation of NF-κB in Human Cancer Cells

  • Ban, Jung-Ok (College of Pharmacy, Chungju National University) ;
  • Cho, Jin-Suk (College of Pharmacy, Chungju National University) ;
  • Hwang, In-Guk (College of Agriculture, Life and Environments Sciences, Chungju National University) ;
  • Noh, Jin-Woo (College of Agriculture, Life and Environments Sciences, Chungju National University) ;
  • Kim, Wun-Jae (Departments of Urology and Biochemistry (SCB), College of Medicine, Institute for Tumor Research, Chungju National University) ;
  • Lee, Ung-Soo (Department of Food and Biotechnology, Chungju National University) ;
  • Moon, Dong-Cheul (College of Pharmacy, Chungju National University) ;
  • Jeong, Heon-Sang (College of Agriculture, Life and Environments Sciences, Chungju National University) ;
  • Lee, Hee-Soon (College of Pharmacy, Chungju National University) ;
  • Hwang, Bang-Yeon (College of Pharmacy, Chungju National University) ;
  • Jung, Jae-Kyung (College of Pharmacy, Chungju National University) ;
  • Han, Sang-Bae (College of Pharmacy, Chungju National University) ;
  • Hong, Jin-Tae (College of Pharmacy, Chungju National University)
  • 발행 : 2009.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Thiacremonone, the main component isolated from heated garlic (Allium sativum L.), is interested for using as a cancer preventive or therapeutic agent since garlic has been known to be useful plant in the treatment of cancers. Nuclear factor kappaB (NF-${\kappa}B$) is constitutively activated in the prostate cancer and activation of NF-${\kappa}B$ is implicated in drug resistance in cancer cells. Docetaxel, a semisynthetic analog of paclitaxel, is an antineoplastic drug widely used for advanced various cancer. In previous studies, we found that thiacremonone inhibited activation of NF-${\kappa}B$ in cancer cells and marcrophages. In the present study, we investigated whether thiacremonone could increase susceptibility of prostate cancer cells (PC-3 and DU145) to docetaxel via inactivation of NF-${\kappa}B$. We found that the combination treatment of thiacremonone (50 ${\mu}g$/ml) with docetaxel (5 nM) was more effective in the inhibition of prostate cancer cell growth and induction of apoptosis accompanied with the significant inhibition of NF-${\kappa}B$ activity than those by the treatment of thiacremonone or docetaxel alone. It was also found that NF-${\kappa}B$ target gene expression of Bax, caspase-3 and caspase-9 was much more significantly enhanced, but the expression of Bcl-2 was also much more significantly inhibited by the combination treatment. These results indicate that thiacremonone inhibits NF-${\kappa}B$, and enhances the susceptibility of prostate cancer cells to docetaxel. Thus, thiacremonone could be useful as an adjuvant anti-cancer agent.

키워드

참고문헌

  1. Andrzejewski, T., Deeb, D., Gao, X., Danyluk, A., Arbab, A. S., Dulchavsky, S. A. and Gautam S. C. (2008). Therapeutic efficacy of curcumin/TRAIL combination regimen for hormonerefractory prostate cancer. Oncol. Res. 17, 257-267. https://doi.org/10.3727/096504008786991611
  2. Ban, J. O., Lee, H. S., Jeong, H. S., Song, S., Hwang, B. Y., Moon, D. C., Yoon, D. Y., Han, S. B. and Hong, J. T. (2009). Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-$\kappa$B. Mol. Cancer Res. 7, 870-879. https://doi.org/10.1158/1541-7786.MCR-08-0580
  3. Ban, J. O., Yuk, D. Y., Woo, K. S., Kim, T. M., Lee, U. S., Jeong, H. S., Kim, D. J., Chung, Y. B., Hwang, B. Y., Oh, K. W. and Hong, J. T. (2007) Inhibition of cell growth and induction of apoptosis via inactivation of NF-$\kappa$B by a sulfurcompound isolated from garlic in human colon cancer cells. J. Pharmacol. Sci. 104, 374-383. https://doi.org/10.1254/jphs.FP0070789
  4. Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M. S. and von Minckwitz, G. (2009). Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs. 13, 49-59. https://doi.org/10.1016/j.ejon.2008.10.003
  5. Barkett, M. and Gilmore, T. D. (1999). Control of apoptosis by Rel/NF-${\kappa}B$ transcription factors. Oncogene 18, 6910-6924. https://doi.org/10.1038/sj.onc.1203238
  6. Chuang, S. E., Yeh, P. Y. and Lu, Y. S. (2002). Basal levels and patterns of anticancer drug-induced activation of nuclear factor- $\kappa$B (NF-$\kappa$B), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem. Pharmacol. 63, 1709-1716. https://doi.org/10.1016/S0006-2952(02)00931-0
  7. Diaz-Rubio, E. (2004). New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers. Oncologist 282-294. https://doi.org/10.1634/theoncologist.9-3-282
  8. Dong, Q. G., Sclabas, G. M. and Fujioka, S. (2002). The function of multiple I$\kappa$B: NF-$\kappa$B complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21, 6510-6519. https://doi.org/10.1038/sj.onc.1205848
  9. Howard, E. W., Lee, D. T., Chiu, Y. T., Chua, C. W., Wang, X. and Wong, Y. C. (2008). Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. Int. J. Cancer 122, 1941-1948. https://doi.org/10.1002/ijc.23355
  10. Hwang, I. K., Woo, K. S., Kim, D. J., Hong, J. T., Hwang, B. Y., Lee, Y. R. and Jeong, H. S. (2007). Isolation and Identification of an Antioxidant Substance from Heated Garlic (Allium sativum L.). Food Sci. Biotechnol. 16, 963-966
  11. Kelloff, G. J. (2000). Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Res. 78, 199-334. https://doi.org/10.1016/S0065-230X(08)61026-X
  12. Kim, J. H., Xu, C., Keum, Y. S., Reddy, B., Conney, A. and Kong, A. N. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with $\beta$-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27, 475-482. https://doi.org/10.1093/carcin/bgi272
  13. Kim, S. M., Lee, S. Y., Yuk, D. Y., Moon, D. C., Choi, S. S., Kim, Y., Han, S. B., Oh, K. W. and Hong, J. T. (2009). Inhibition of NF-$\kappa$B by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 32, 755-765. https://doi.org/10.1007/s12272-009-1515-4
  14. Kwon, O. C., Woo, K. S., Kim, T. M., Kim, D. J., Hong, J. T. and Jeong, H. S. (2006). Physicochemical characteristics of garlic (Allium sativum L.) on the high temperature and pressure treatment. Korean J. Food Sci. Technol. 38, 331-336.
  15. Millikan, R., Baez, L., Banerjee, T., Wade, J., Edwards, K., Winn, R., Smith, T. L. and Logothetis, C. (2001). Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer. Urol. Oncol. 6, 111-115. https://doi.org/10.1016/S1078-1439(00)00123-X
  16. Nakagawa, H., Tsuta, K., Kiuchi, K., Senzaki, H., Tanaka, K., Hioki, K. and Tsubura, A. (2001). Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22, 891-897. https://doi.org/10.1093/carcin/22.6.891
  17. Ojima, I., Kuduk, S. D., Slater, J. C., Gimi, R. H. and Sun, C. M. (1996). Syntheses of new fluorine-containing taxoids by means of ${\beta}$-lactam synthon method. Tetrahedron 52, 209-224. https://doi.org/10.1016/0040-4020(95)00865-6
  18. Ortiz, M. A., Bayon, Y., Lopez-Hernandez, F. J. and Piedrafita, F. J. (2002). Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist. Updat. 5, 162-175. https://doi.org/10.1016/S1368-7646(02)00050-X
  19. Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N. and Price, B. D. (1999). Constitutive activation of I$\kappa$ B $\alpha$ and NF-$\kappa$B in prostate cancer cells is inhibited by ibuprofen. Oncogene 18, 7389-7394. https://doi.org/10.1038/sj.onc.1203160
  20. Pares, A., Planas, R., Torres, M., Caballeria, J., Viver, J. M., Acero, D., Panes, J., Rigau, J., Santos, J. and Rodes, J. (1998). Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J. Hepatol. 28, 615-621. https://doi.org/10.1016/S0168-8278(98)80285-7
  21. Qadan, L. R., Perez-Stable, C. M., Anderson, C., D'ppolito, G., Herron, A., Howard, G. A. and Roos, B. A. (2001). 2-Methoxyestradiol induces G2-M arrest and apoptosis in prostate cancer. Biochem. Biophys. Res. Commun. 285, 1259-1266. https://doi.org/10.1006/bbrc.2001.5320
  22. Rosenberg, J. E., Ryan, C. J., Weinberg, V. K., Smith, D. C., Hussain, M., Beer, T. M., Ryan, C. W., Mathew, P., Pagliaro, L. C., Harzstark, A. L., Sharib, J. and Small, E. J. (2009). Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortium. J. Clin. Oncol. 27, 2772-2778. https://doi.org/10.1200/JCO.2008.19.8002
  23. Ryan, D. P., Kulke, M. H., Fuchs, C. S., Grossbard, M. L., Grossman, S. R., Morgan, J. A., Earle, C. C., Shivdasani, R., Kim, H., Mayer, R. J. and Clark, J. W. (2002). A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer 94, 97-103. https://doi.org/10.1002/cncr.10202
  24. Sabayan, B., Foroughinia, F. and Chohedry, A. (2007). A postulated role of garlic organosulfur compounds in prevention of valproic acid hepatotoxicity. Med. Hypotheses. 68, 512-514. https://doi.org/10.1016/j.mehy.2006.07.055
  25. Sarafraz, M. and Ahmadi, K. (2008). Paraclinical evaluation of side-effects of Taxanes on auditory system. Acta. Otorhinolaryngol. Ital. 28, 239-242.
  26. Scifo, C., Milasi, A., Guarnera, A., Sinatra, F. and Renis, M. (2006). Resveratrol and propolis extract: an insight into the morphological and molecular changes induced in DU145 cells. Oncol. Res. 15, 409-421.
  27. Shaikh, I. A., Brown, I., Schofield, A. C., Wahle, K. W. and Heys, S. D. (2008). Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate 68, 1635-1646. https://doi.org/10.1002/pros.20830
  28. Shigemura, K., Arbiser, J. L., Sun, S. Y., Zayzafoon, M., Johnstone, P. A., Fujisawa, M., Gotoh, A., Weksler, B., Zhau, H. E. and Chung, L. W. (2007). Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109, 1279-1289. https://doi.org/10.1002/cncr.22551
  29. Singh, R. P., Tyagi, A. K., Zhao, J. and Agarwal, R. (2002). Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis Lond. 23, 499-510. https://doi.org/10.1093/carcin/23.3.499
  30. Sporn. M. B. and Suh. N. (2000). Chemoprevention of cancer. Carcinogenesis Lond. 21, 525-530. https://doi.org/10.1093/carcin/21.3.525
  31. Sun, L. C., Luo, J., Mackey, L. V., Fuselier, J. A. and Coy, D. H. (2007). A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3 K/Akt, $\alpha$V$\alpha$3/$\alpha$V$\alpha$5 and MMP-2/-9. Cancer Lett. 246, 157-166. https://doi.org/10.1016/j.canlet.2006.02.016
  32. Tedesco, K. L., Thor, A. D., Johnson, D. H., Shyr, Y., Blum, K. A., Goldstein, L. J., Gradishar, W. J., Nicholson, B. P., Merkel, D. E., Murrey, D., Edgerton, S. and Sledge, G. W. (2004). Docetaxel combined with trastuzumab is an active regimen in HER-2 3＋overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J. Clin. Oncol. 15, 1071-1077. https://doi.org/10.1200/JCO.2004.10.046
  33. Uzzo, R. G., Leavis, P. and Hatch, W. (2002). Zinc inhibits nuclear factorkappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin. Cancer Res. 8, 3579-3583.
  34. Waddick, K. G. and Uckun, F. M. (1999). Innovative treatment programs against cancer: II. Nuclear factor-${\kappa}B$ (NF-${\kappa}B$) as a molecular target. Biochem. Pharmacol. 57, 9-17. https://doi.org/10.1016/S0006-2952(98)00224-X
  35. Wang, C. Y., Mayo, M. W. and Baldwin, A. S. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-${\kappa}B$. Science 274, 784-787. https://doi.org/10.1126/science.274.5288.784
  36. Wang, W. and Cassidy, J. (2003). Constitutive nuclear factorkappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitorresistant tumour cells. Br. J. Cancer 88, 624-629. https://doi.org/10.1038/sj.bjc.6600753
  37. Yance, D. R. and Sagar, S. M. (2006). Targeting angiogenesis with integrative cancer therapies. Integr. Cancer Ther. 5, 9-29. https://doi.org/10.1177/1534735405285562
  38. Zhang, H., Morisaki, T. and Nakahara, C. (2003). PSK-mediated NF-$\kappa$B inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene 22, 2088-2096. https://doi.org/10.1038/sj.onc.1206310

피인용 문헌

  1. Aged Red Garlic Extract Reduces Cigarette Smoke Extract-induced Cell Death in Human Bronchial Smooth Muscle Cells by Increasing Intracellular Glutathione Levels vol.26, pp.1, 2012, https://doi.org/10.1002/ptr.3502